Search

everythinglearnresearchcommunity

for

Search:↓

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

These new skin treatments are safer and more effective with minimal side effects.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Abrocitinib may effectively treat Lichen Planopilaris.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.